Browsing byAuthorCawley, A

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 11 to 19 of 19< previous 
Issue DateTitleAuthor(s)
2020-07-05Finding the proverbial needle: Non-targeted screening of synthetic opioids in equine plasma.Klingberg, J; Cawley, A; Shimmon, R; Fouracre, C; Pasin, D; Fu, S
2022-05Intelligence benefit of the 3-methoxytyramine to tyramine ratio in equine urine.Elbourne, M; Cawley, A; Stanley, S; Bowen, C; Fu, S
2022-05Measurements of hydrocortisone and cortisone for longitudinal profiling of equine plasma by liquid chromatography-tandem mass spectrometry.Tou, K; Cawley, A; Bowen, C; Sornalingam, K; Fu, S
2022-09Metabolomic analysis of equine urine to determine route of altrenogest administrationElbourne, M; Fu, S; Cawley, A; Bowen, C; Gupta, A
2022-05Metabolomics in clinical and forensic toxicology, sports anti-doping and veterinary residues.Keen, B; Cawley, A; Reedy, B; Fu, S
2016-02-28The potential for complementary targeted/non-targeted screening of novel psychoactive substances in equine urine using liquid chromatography-high resolution accurate mass spectrometryCawley, A; Pasin, D; Ganbat, N; Ennis, L; Smart, C; Greer, C; Keledjian, J; Fu, S; Chen, A
2021-05Towards an untargeted mass spectrometric approach for improved screening in equine antidoping.Keen, B; Cawley, A; Fouracre, C; Pyke, J; Fu, S
2020-11-18Towards Compound Identification of Synthetic Opioids in Non-targeted Screening Using Machine Learning Techniques.Klingberg, J; Cawley, A; Shimmon, R; Fu, S
2022-12-30Towards Non-Targeted Screening of Lipid Biomarkers for Improved Equine Anti-Doping.Tou, K; Cawley, A; Bowen, C; Bishop, DP; Fu, S